Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Farzin Sohraby

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Computational Biology and Chemistry|December 9, 2021
Reconstruction of the binding pathway of an anti-HIV drug, Indinavir, in complex with the HTLV-1 protease using unaggregated unbiased molecular dynamics simulationFarzin Sohraby, Hassan Aryapour
Plos One|September 27, 2021
Comparative analysis of the unbinding pathways of antiviral drug Indinavir from HIV and HTLV1 proteases by supervised molecular dynamics simulationFarzin Sohraby, Hassan Aryapour
Plos One|May 19, 2021
Unraveling the unbinding pathways of SARS-CoV-2 Papain-like proteinase known inhibitors by Supervised Molecular Dynamics simulationFarzin Sohraby, Hassan Aryapour
Seminars in Cancer Biology|May 4, 2020
Rational drug repurposing for cancer by inclusion of the unbiased molecular dynamics simulation in the structure-based virtual screening approach: Challenges and breakthroughsFarzin Sohraby, Hassan Aryapour
Journal of Chemical Information and Modeling|May 10, 2024
Characterization of the Bottlenecks and Pathways for Inhibitor Dissociation from [NiFe] HydrogenaseFarzin Sohraby, Ariane Nunes-Alves
The Journal of Physical Chemistry Letters|July 29, 2025
Symmetric Ligand Binding Pathways and Dual-State Bottleneck in [NiFe] Hydrogenases from Unbiased Molecular DynamicsFarzin Sohraby, Ariane Nunes-Alves
Trends in Biochemical Sciences|December 24, 2022
Advances in computational methods for ligand binding kineticsFarzin Sohraby, Ariane Nunes-Alves
Methods in Molecular Biology (Clifton, N.J.)|December 15, 2018
Performing an In Silico Repurposing of Existing Drugs by Combining Virtual Screening and Molecular Dynamics SimulationFarzin Sohraby, Milad Bagheri, Hassan Aryapour
Computational Biology and Chemistry|October 10, 2017
Prediction of new chromene-based inhibitors of tubulin using structure-based virtual screening and molecular dynamics simulation methodsHassan Aryapour, Maryam Dehdab, Farzin Sohraby, et al.
Journal of Molecular Graphics & Modelling|May 2, 2017
In silico drug repurposing of FDA-approved drugs to predict new inhibitors for drug resistant T315I mutant and wild-type BCR-ABL1: A virtual screening and molecular dynamics studyFarzin Sohraby, Milad Bagheri, Masoud Aliyar, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Computational Biology and Chemistry|December 9, 2021
Reconstruction of the binding pathway of an anti-HIV drug, Indinavir, in complex with the HTLV-1 protease using unaggregated unbiased molecular dynamics simulationFarzin Sohraby, Hassan Aryapour
Plos One|September 27, 2021
Comparative analysis of the unbinding pathways of antiviral drug Indinavir from HIV and HTLV1 proteases by supervised molecular dynamics simulationFarzin Sohraby, Hassan Aryapour
Plos One|May 19, 2021
Unraveling the unbinding pathways of SARS-CoV-2 Papain-like proteinase known inhibitors by Supervised Molecular Dynamics simulationFarzin Sohraby, Hassan Aryapour
Seminars in Cancer Biology|May 4, 2020
Rational drug repurposing for cancer by inclusion of the unbiased molecular dynamics simulation in the structure-based virtual screening approach: Challenges and breakthroughsFarzin Sohraby, Hassan Aryapour
Journal of Chemical Information and Modeling|May 10, 2024
Characterization of the Bottlenecks and Pathways for Inhibitor Dissociation from [NiFe] HydrogenaseFarzin Sohraby, Ariane Nunes-Alves
The Journal of Physical Chemistry Letters|July 29, 2025
Symmetric Ligand Binding Pathways and Dual-State Bottleneck in [NiFe] Hydrogenases from Unbiased Molecular DynamicsFarzin Sohraby, Ariane Nunes-Alves
Trends in Biochemical Sciences|December 24, 2022
Advances in computational methods for ligand binding kineticsFarzin Sohraby, Ariane Nunes-Alves
Methods in Molecular Biology (Clifton, N.J.)|December 15, 2018
Performing an In Silico Repurposing of Existing Drugs by Combining Virtual Screening and Molecular Dynamics SimulationFarzin Sohraby, Milad Bagheri, Hassan Aryapour
Computational Biology and Chemistry|October 10, 2017
Prediction of new chromene-based inhibitors of tubulin using structure-based virtual screening and molecular dynamics simulation methodsHassan Aryapour, Maryam Dehdab, Farzin Sohraby, et al.
Journal of Molecular Graphics & Modelling|May 2, 2017
In silico drug repurposing of FDA-approved drugs to predict new inhibitors for drug resistant T315I mutant and wild-type BCR-ABL1: A virtual screening and molecular dynamics studyFarzin Sohraby, Milad Bagheri, Masoud Aliyar, et al.
Pageof 2